Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Quantification of Glomerular Structural Lesions: Associations With Clinical Outcomes and Transcriptomic Profiles in Nephrotic Syndrome
Jeffrey B. Hodgin, Laura Mariani, Jarcy Zee, et al.
American Journal of Kidney Diseases (2021) Vol. 79, Iss. 6, pp. 807-819.e1
Open Access | Times Cited: 19

Showing 19 citing articles:

Mechanisms of podocyte injury and implications for diabetic nephropathy
Federica Barutta, Stefania Bellini, Gabriella Gruden
Clinical Science (2022) Vol. 136, Iss. 7, pp. 493-520
Open Access | Times Cited: 113
Spatial transcriptomics in health and disease
Sanjay Jain, Michael T. Eadon
Nature Reviews Nephrology (2024) Vol. 20, Iss. 10, pp. 659-671
Closed Access | Times Cited: 19
Rationale and design of the Nephrotic Syndrome Study Network (NEPTUNE) Match in glomerular diseases: designing the right trial for the right patient, today
Howard Trachtman, Hailey Desmond, Amanda Williams, et al.
Kidney International (2024) Vol. 105, Iss. 2, pp. 218-230
Open Access | Times Cited: 10
Framework for precision medicine in focal segmental glomerulosclerosis: Translation of sparsentan-responsive genes in a rat model to kidney disease associated proteins in biofluids
Sean Eddy, Viji Nair, John R. Hartman, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Leveraging complementary multi-omics data integration methods for mechanistic insights in kidney diseases
Fadhl Alakwaa, Vivek Das, Årindam Majumdar, et al.
JCI Insight (2025) Vol. 10, Iss. 5
Open Access
Clinical Relevance of Computationally Derived Attributes of Peritubular Capillaries from Kidney Biopsies
Yijiang Chen, Jarcy Zee, Andrew Janowczyk, et al.
Kidney360 (2023) Vol. 4, Iss. 5, pp. 648-658
Open Access | Times Cited: 12
Present and future directions in diabetic kidney disease
Christine P. Limonte, Matthias Kretzler, Subramaniam Pennathur, et al.
Journal of Diabetes and its Complications (2022) Vol. 36, Iss. 12, pp. 108357-108357
Open Access | Times Cited: 13
Identification of Glomerular and Plasma Apolipoprotein M as Novel Biomarkers in Glomerular Disease
Yelena Drexler, Judith Molina, Tali Elfassy, et al.
Kidney International Reports (2023) Vol. 8, Iss. 4, pp. 884-897
Open Access | Times Cited: 7
Precision Medicine in Nephrology: An Integrative Framework of Multidimensional Data in the Kidney Precision Medicine Project
Tarek M. El‐Achkar, Michael T. Eadon, Matthias Kretzler, et al.
American Journal of Kidney Diseases (2023) Vol. 83, Iss. 3, pp. 402-410
Closed Access | Times Cited: 7
Therapeutic trials in difficult to treat steroid sensitive nephrotic syndrome: challenges and future directions
Ashlene McKay, Rulan S. Parekh, Damien Noone
Pediatric Nephrology (2022) Vol. 38, Iss. 1, pp. 17-34
Open Access | Times Cited: 8
Hederagenin Improves Adriamycin-induced Nephropathy by Inhibiting the JAK/STAT Signaling Pathway
Xia Zhong, Jian Jia, Ruizhi Tan, et al.
Integrative Medicine in Nephrology and Andrology (2024) Vol. 11, Iss. 2
Closed Access | Times Cited: 1
Defining diagnostic trajectories in patients with podocytopathies
Luigi Cirillo, Gianmarco Lugli, Valentina Raglianti, et al.
Clinical Kidney Journal (2022) Vol. 15, Iss. 11, pp. 2006-2019
Open Access | Times Cited: 6
Should we integrate the gut microbiota composition to manage idiopathic nephrotic syndrome?
Maxime Espi, Christophe O. Soulage, Laetitia Koppe
Nephrology Dialysis Transplantation (2023) Vol. 38, Iss. 9, pp. 1927-1930
Open Access | Times Cited: 2
Impact of Gene Therapy and Genetic Mutations in Rare Diseases
Venkatarangaiah Krishna, Ch. Kesari
Journal of Clinical and Pharmaceutical Research (2024)
Open Access
Type I IFN in Glomerular Disease: Scarring beyond the STING
Alexis Paulina Jiménez‐Uribe, Steve Mangos, Eunsil Hahm
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2497-2497
Open Access
ANALYSIS OF GLOMERULAR TRANSCRIPTOMES FROM NEPHROTIC PATIENTS SUGGEST APOL1 RISK VARIANTS IMPACT PARIETAL EPITHELIAL CELLS
Agustin Gonzalez‐Vicente, Dana C. Crawford, William S. Bush, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Proteomic profiling of kidney biopsies in nephrotic syndrome
Emily L. Williams, Maryline Fresquet, Anna S Li, et al.
Wellcome Open Research (2024) Vol. 9, pp. 731-731
Open Access
Clinical Course of Adult FSGS and Minimal Change Disease in North American and Japanese Cohorts
Takaya Ozeki, Brenda W. Gillespie, Maria Larkina, et al.
Kidney360 (2023)
Open Access | Times Cited: 1
Outscoring Current Classification Systems for Nephrotic Syndrome
Gentzon Hall, Jennie Lin
American Journal of Kidney Diseases (2022) Vol. 79, Iss. 6, pp. 783-784
Open Access
Page 1

Scroll to top